In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Arno Therapeutics Inc.

Latest From Arno Therapeutics Inc.

Tech Transfer Roundup: GE Healthcare, Vanderbilt Partner To Optimize Precision Cancer Immunotherapy

Five-year collaboration will analyze data from thousands of cancer patients to optimize immunotherapy treatment and develop PET imaging tracers to stratify clinical trial participants. Also, MD Anderson starts 2019 with three new agreements.

Deals Commercial

Deal Watch: From The Sidelines Of J.P. Morgan, Lots Of Discovery Deals

Strongbridge obtains rights from AEterna Zentaris to first drug approved for adult growth hormone deficiency. While the J.P. Morgan Healthcare Conference didn't have many major deal announcements, there was a flurry of announcements around discovery and development capabilities.

Deals Business Strategies

Oncobiologics Appoints CFO

Oncobiologics Inc. has appointed Lawrence Kenyon as its chief financial officer. Kenyon's most recent positions were at Arno Therapeutics Inc. (chief operating officer and CFO) and Tamir Biotechnology Inc. (interim president, chief executive officer and CFO).


Execs On The Move, January 2015

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Arno Therapeutics Inc.
  • Senior Management
  • Alexander Zukiwski, MD, CEO & CMO
    Stefan Proniuk, PhD, Chief Dev. Officer
  • Contact Info
  • Arno Therapeutics Inc.
    Phone: (862) 703-7170
    200 Route 31 North
    Ste. 104
    Flemington, NJ 08822